04
1. MR Prausnitz, VG Bose, R Langer and JC Weaver (1993) Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery, Proc. Natl. Acad. Sci. USA 90: 10504-10508.
2. MR Prausnitz, BS Lau, CD Milano, S Conner, R Langer and JC Weaver (1993) A quantitative study of electroporation showing a plateau in net molecular transport, Biophys. J. 65: 414-422.
3. MR Prausnitz, DS Seddick, AA Kon, VG Bose, S Frankenburg, SN Klaus, R Langer and JC Weaver (1993) Methods for in vivo tissue electroporation using surface electrodes, Drug Delivery 1: 125-131.
4. MR Prausnitz, CD Milano, JA Gimm, R Langer and JC Weaver (1994) Quantitative study of molecular transport due to electroporation: uptake of bovine serum albumin by erythrocyte ghosts, Biophys. J. 66: 1522-1530.
5. MR Prausnitz, U Pliquett, R Langer and JC Weaver (1994) Rapid temporal control of transdermal drug delivery by electroporation, Pharm. Res. 11: 1834-1837.
6. U Pliquett, MR Prausnitz, YA Chizmadzhev and JC Weaver (1995) Measurement of rapid release kinetics for drug delivery, Pharm. Res. 12: 549-555 (Errata in Pharm. Res. 12:1244).
7. MR Prausnitz, JD Corbett, JA Gimm, DE Golan, R Langer and JC Weaver (1995) Millisecond measurement of transport during and after an electroporation pulse, Biophys. J. 68: 1864-1870.
8. DA Edwards, MR Prausnitz, R Langer and JC Weaver (1995) Analysis of enhanced transdermal transport by skin electroporation, J. Control. Rel. 34: 211-221.
9. MR Prausnitz, VG Bose, R Langer and JC Weaver (1995) Electroporation, in Percutaneous Penetration Enhancers, HI Maibach and EW Smith, eds., CRC Press, Boca Raton, FL, pp. 393-405.
10. MR Prausnitz, ER Edelman, JA Gimm, R Langer and JC Weaver (1995) Transdermal delivery of heparin by skin electroporation, Bio/Technology 13: 1205-1209.
11. MR Prausnitz, I Cordero and A Levenson (1995) Focus on: ORBIS International flying eye hospital, department of technical services, J. Clin. Eng. 20: 388-393.
12. MR Prausnitz (1996) The effects of current applied to the skin: a review for transdermal drug delivery, Adv. Drug Deliv. Rev. 18: 395-425.
13. MR Prausnitz, CS Lee, CH Liu, JC Pang, T-P Singh, R Langer and JC Weaver (1996) Transdermal transport efficiency during skin electroporation and iontophoresis, J. Control. Rel. 38: 205-217.
14. MR Prausnitz, JA Gimm, JC Weaver, RH Guy, R Langer and C Cullander (1996) Imaging regions of transport across human stratum corneum during high-voltage and low-voltage exposures, J. Pharm. Sci. 85: 1363-1370.
15. MR Prausnitz (1996) Do high-voltage pulses cause changes in skin structure?, J. Control. Rel. 40: 321-326.
16. R Vanbever, MR Prausnitz and V Préat (1997) Macromolecules as novel transdermal transport enhancers for skin electroporation, Pharm. Res. 14: 638-644.
17. JC Weaver, R Vanbever, T Vaughan, and MR Prausnitz (1997) Heparin alters transdermal transport associated with electroporation, Biochem. Biophys. Res. Comm. 234: 637-640.
18. MR Prausnitz (1997) Reversible skin permeabilization for transdermal delivery of macromolecules, Crit. Rev. Ther. Drug Carrier Sys. 14: 455-483.
19. MR Prausnitz (1997) Transdermal delivery of proteins: recent advances by modification of skin's barrier properties in Therapeutic Protein and Peptide Formulation and Delivery, Z Shahrokh, V Sluzky, J. Cleland, S Shire, and T Randolph, eds., American Chemical Society, Washington, DC, pp. 124-153.
20. MR Prausnitz (1998) Electroporation in Electronically-Controlled Drug Delivery, B Berner and SM Dinh, eds., CRC Press, Boca Raton, FL, pp. 185-214.
21. A Edwards and MR Prausnitz (1998) Fiber matrix model of sclera and corneal stroma for drug delivery to the eye AIChE J. 44: 214-225.
22. MR Prausnitz (1998) COMET: An open-ended, hands-on design project for chemical engineering sophomores, Chem. Eng. Ed. 32: 20-23, 45.
23. S Henry, DV McAllister, MG Allen and MR Prausnitz (1998) Microfabricated microneedles: A novel approach to transdermal drug delivery, J. Pharm Sci. 87: 922-925.
24. A Banga and MR Prausnitz (1998) Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs, Trends Biotech. 16: 408-412.
25. J Liu, T Lewis and MR Prausnitz (1998) Non-invasive assessment and control of ultrasound-mediated membrane permeabilization, Pharm. Res. 15: 920-926.
26. MR Prausnitz, A Edwards, JS Noonan, DE Rudnick, HF Edelhauser and DH Geroski (1998) Measurement and prediction of transient transport across sclera for drug delivery to the eye, Ind. Eng. Chem. Res. 37: 2903-2907.
27. MR Prausnitz and JS Noonan (1998) Permeability of cornea, sclera and conjunctiva: A literature analysis for drug delivery to the eye, J. Pharm. Sci. 87: 1479-1488.
28. MR Prausnitz (1999) A practical assessment of transdermal drug delivery by skin electroporation, Adv. Drug Deliv. Rev. 35: 61-76.
29. MR Prausnitz, U Pliquett and R Vanbever (1999) Mechanistic studies of skin electroporation using biophysical methods in Electrically Mediated Delivery of Molecules to Cells — Electrochemotherapy, Electrogenetherapy, and Transdermal Delivery by Electroporation, MJ Jaroszeski, R Gilbert, and R Heller, eds., Humana Press, Totowa, NJ, pp. 214-235.
30. U Pliquett and MR Prausnitz (1999) Electrical impedance spectroscopy for rapid and non-invasive analysis of skin electroporation in Electrically Mediated Delivery of Molecules to Cells — Electrochemotherapy, Electrogenetherapy, and Transdermal Delivery by Electroporation, MJ Jaroszeski, R. Gilbert, and R. Heller, eds., Humana Press, Totowa, NJ, pp. 377-406.
31. DE Rudnick, JS Noonan, DH Geroski, MR Prausnitz and HF Edelhauser (1999) The effect of intraocular pressure on scleral permeability, Invest. Ophthalmol. Vis. Sci. 40:3054-3058.
32. DV McAllister, MG Allen and MR Prausnitz (2000) Microfabricated microneedles for gene and drug delivery, Annu. Rev. Biomed. Eng. 2: 289-313.
33. MR Prausnitz and MJ Bradley (2000) Effective communication for professional engineering: Beyond problem sets and lab reports, Chem. Eng. Ed. 34: 234-237.
34. PJ Canatella, JF Karr, JA Petros and MR Prausnitz (2001) Quantitative study of electroporation-mediated molecular uptake and cell viability, Biophys. J. 80: 755-764.
35. S Kaushik, AH Hord, DD Denson, DV McAllister, S Smitra, MG Allen and MR Prausnitz (2001) Lack of pain associated with microfabricated microneedles, Anesth. Analg. 92: 502-504.
36. S Kaushik, A Krishnan, MR Prausnitz and PJ Ludovice (2001) Magainin-mediated disruption of stratum corneum lipid vesicles, Pharm. Res. 18: 894-896.
37. HR Guzman, DX Nguyen, S Kahn and MR Prausnitz (2001) Ultrasound-mediated disruption of cell membranes I: Quantification of molecular uptake and cell viability, J. Acoust. Soc. Am. 110: 588-596.
38. HR Guzman, DX Nguyen, S Kahn and MR Prausnitz (2001) Ultrasound-mediated disruption of cell membranes II: Heterogeneous effects on cells, J. Acoust. Soc. Am. 110: 597-606.
39. SA Cochran and MR Prausnitz (2001) Sonoluminescence as an indicator of cell membrane disruption by acoustic cavitation, Ultrasound Med. Biol. 27: 841-850.
40. MR Prausnitz (2001) Overcoming skin’s barrier: The search for effective and user-friendly drug delivery, Diabetes Technol. Ther. 3: 233-236.
41. A Edwards and MR Prausnitz (2001) Predicted permeability of the cornea to topical drugs, Pharm. Res. 18: 1497-1508.
42. PJ Canatella and MR Prausnitz (2001) Prediction and optimization of gene transfection and drug delivery by electroporation, Gene Ther. 8: 1464-1469.
43. K Keyhani, HR Guzman, A Parsons, TN Lewis and MR Prausnitz (2001) Intracellular drug delivery using low-frequency ultrasound: Quantification of molecular uptake and cell viability, Pharm. Res. 18: 1514-1520.
44. HR Guzman, DX Nguyen, AJ McNamara and MR Prausnitz (2002) Equilibrium loading of cells with macromolecules by ultrasound: Effects of molecular size and acoustic energy, J. Pharm. Sci. 91: 1693-1701.
45. MR Prausnitz, D Ackley and JR Gyory (2003) Microneedles for transdermal drug delivery in Modified Release Drug Delivery Systems, M Rathbone, J Hadgraft and M Roberts, eds., Marcel Dekker, New York, pp. 513-522.
46. AL Coulberson, NV Hud, JM LeDoux, I Vilfan and MR Prausnitz (2003) Gene packaging with lipids, peptides and viruses inhibits transfection by electroporation in vitro, J. Controlled Release 86: 361-970.
47. HR Guzman, AJ McNamara, DX Nguyen and MR Prausnitz (2003) Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: A unified explanation based on cell-to-bubble ratio and blast radius, Ultrasound Med. Biol. 29: 1211-1222.
48. DV McAllister, PM Wang, SP Davis, J-H Park, PJ Canatella, MG Allen and MR Prausnitz (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies, Proc. Nat. Acad. Sci. (USA) 100: 13755-13760.
49. EK Lee, RJ Gallagher, AM Campbell and MR Prausnitz (2004) Prediction of ultrasound-mediated disruption of cell membranes using machine learning techniques and statistical analysis of acoustic spectra, IEEE Trans. Biomed. Eng. 51: 82-89.
50. EB Ghartey-Tagoe, JS Morgan, K Ahmed, AS Neish and MR Prausnitz (2004) Electroporation-mediated delivery of macromolecules to model intestinal epithelia, Int. J. Pharm. 270: 127-138.
51. MR Prausnitz, S Mitragotri, R Langer (2004) Current status and future potential of transdermal drug delivery, Nat. Rev. Drug Discov. 3: 115-124.
52. S-B Lee, HF Edelhauser, JS Noonan, MR Prausnitz and DH Geroski (2004) Drug delivery through the sclera: Effects of thickness, hydration and sustained release systems, Exp. Eye Res. 78: 599-607.
53. PP Kamaev, JD Hutcheson, M. Wilson and MR Prausnitz (2004) Quantification of optison bubble size and lifetime during sonication dominant role of secondary cavitation bubbles causing acoustic bioeffects, J. Acoust. Soc. Am. 115 : 1818-1825
54. MR Prausnitz (2004) Microneedles for transdermal drug delivery, Adv. Drug Deliv. Rev. 56: 581-587
55. PJ Canatella, MM Black, DM Bonnichsen, C McKenna and MR Prausnitz (2004) Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environments, Biophys. J. 86: 3260-3268
56. SP Davis, BJ Landis, ZH Adams, MG Allen and MR Prausnitz (2004) Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force, J. Biomech. 37: 1155-1163
57. W Martanto, SP Davis, NR Holiday, J Wang, HS Gill and MR Prausnitz (2004) Transdermal delivery of insulin using microneedles in vivo, Pharm. Res. 21: 947-952
58. VG Zarnitsyn and MR Prausnitz (2004) Physical parameters influencing optimization of ultrasound-mediated DNA transfection, Ultrasound Med. Biol. 30: 527-538
59. W Zhang, MR Prausnitz, A Edwards (2004) Model of transient drug diffusion across cornea, J Control. Release 99 : 241-258
60. EB Ghartey-Tagoe, JS Morgan, AS Neish, MR Prausnitz (2005) Increased permeability of intestinal epithelial monolayers mediated by electroporation, J Control. Release 103 : 177-190
61. JH Park, MG Allen, MR Prausnitz (2005) Biodegradable polymer microneedles : Fabrication, mechanics and transdermal drug delivery, J Control. Release 104 : 51-66
62. PM Wang , M Cornwell , MR Prausnitz (2005) Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles, Diabetes Technol Ther.7 : 131-141
63. SP Davis, W martanto, MG Allen, MR Prausnitz (2005) Hollow metal microneedle for insulin delivery to diabetic rats (2005) IEEE Transactions on Biomed. Eng. 52 : 909-915
